Overview
A global biotechnology organization is seeking a remote Investment Analyst based in New York, USA. The role supports the investment team in managing a buy-side investment pipeline focused on licensed healthcare assets and novel biotherapeutics targeting difficult-to-treat diseases such as cancer, inflammation, and autoimmune disorders.
Responsibilities
- Manage and track the investment pipeline, ensuring timely progression of active opportunities.
- Maintain and update project databases including opportunity status, counterparty records, and transaction history.
- Build, maintain, and refine complex financial models in Excel to support investment evaluations, including royalty, asset, and business valuations using NPV and rNPV methodologies.
- Conduct data analysis for investment forecasting, competitive benchmarking, and provide quantitative insights.
- Assist in scientific and financial due diligence on licensing and equity investment opportunities, synthesizing technical, clinical, and financial information.
- Prepare clear and concise due diligence findings presentations capturing key scientific, strategic, and financial considerations.
- Develop and maintain high-quality presentation materials such as investment presentations, opportunity assessments, and deal summaries for internal and Board-level reviews.
- Coordinate with internal teams including Technical, Legal, Finance, and Operations to support due diligence and transaction execution.
- Monitor the competitive investment landscape, tracking deal activity, valuations, emerging technologies, and biotech financing trends; compile regular briefings.
- Support administrative functions including scheduling, document management, and logistical coordination to facilitate an efficient deal process.
- Undertake additional analytical and project-based tasks as assigned to support the investment function.
Requirements
- 2-5 years of experience in investment banking, corporate development, private equity, venture capital, management consulting, or a similar analytical role within life sciences or healthcare; exceptional recent graduates with relevant internships may also be considered.
- Bachelor’s degree in life sciences, finance, business, or a quantitative discipline.
- Scientific background in biology, biochemistry, pharmacology, or related fields sufficient to understand drug development programs and investment opportunities.
- Exposure to equity investment, venture capital, private equity, or asset valuation in biotechnology or life sciences is a strong asset.
- Advanced financial modeling skills, including building and interpreting complex models.
- Scientific literacy to critically evaluate drug development programs and engage with R&D teams during due diligence.
- Strong project management skills with the ability to manage multiple concurrent workstreams and meet deadlines.
- Excellent analytical and data synthesis capabilities to convert large volumes of information into actionable insights.
- Strong written and verbal communication skills for producing polished due diligence summaries, investment memos, and presentations.
- Highly organized, detail-oriented, and able to work independently with minimal oversight.
- Collaborative and proactive communicator comfortable working across cross-functional teams.
- Self-motivated with intellectual curiosity about biotechnology, drug development, and life sciences investment.
- Proficiency with Excel, PowerPoint, and other Microsoft Office tools.
Compensation & Benefits
- Salary range: $71,000 - $109,000 USD per year (New York, NY)
- Competitive base salary with additional bonus, equity, and benefits
- Industry-leading vacation and paid time off
- Comprehensive medical, dental, and vision benefits
- Health and wellness programs
- Matching retirement savings plans (RRSP / 401K / Pension)
- Employee Share Purchase and Equity Programs
- Paid volunteer time off
This role is not eligible for relocation or immigration support.
Location
Remote position requiring candidates to be located in New York, USA.
All qualified applicants will receive consideration without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or disability.